Brief: Alligator Bioscience Resolves On Directed Issue Of 18,585,000 Units
Jan 7 (Reuters) - Alligator Bioscience AB ATORX.ST: RESOLVES ON DIRECTED ISSUE OF 18,585,000 UNITS SUBSCRIPTION PRICE IN COMPENSATION ISSUE IS SEK 0.40 PER UNIT DIRECTED ISSUE OF 28,132,473 WARRANTS TO FENJA CAPITAL Source text: ID:nMFN1sQCt Further company coverage: ATORX.ST (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Alligator Bioscience AB
See all newsSweden's Alligator Bioscience Q3 sales fall as R&D winds down
Brief: Alligator Bioscience Q3 EBIT SEK -19.3 Million
Brief: Alligator Bioscience Appoints Johan Gileus As CEO
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
Brief: Alligator Bioscience To Initially Receive SEK 58.8 Mln From Rights Issue